Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hom

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Journal of Clinical Microbiology|May 23, 2008
Development of multiplex PCR-ligase detection reaction assay for detection of West Nile virusS Rondini, M R Pingle, S Das, et al.
Bioorganic & Medicinal Chemistry Letters|September 15, 2000
Potent, selective 3-pyridylethanolamine beta3 adrenergic receptor agonists possessing a thiazole benzenesulfonamide pharmacophoreR J Mathvink, J S Tolman, D Chitty, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2000
Human beta3-adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamidesL L Brockunier, E R Parmee, H O Ok, et al.
Bioorganic & Medicinal Chemistry Letters|July 29, 2000
Substituted oxazole benzenesulfonamides as potent human beta3 adrenergic receptor agonistsH O Ok, L B Reigle, M R Candelore, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2001
Beta(3)-adrenoceptor agonist-induced increases in lipolysis, metabolic rate, facial flushing, and reflex tachycardia in anesthetized rhesus monkeysG J Hom, M J Forrest, T J Bach, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
3-Pyridylethanolamines: potent and selective human beta 3 adrenergic receptor agonistsE M Naylor, V J Colandrea, M R Candelore, et al.
Bioorganic & Medicinal Chemistry Letters|May 26, 1999
L-770,644: a potent and selective human beta3 adrenergic receptor agonist with improved oral bioavailabilityT L Shih, M R Candelore, M A Cascieri, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2000
Discovery of an orally bioavailable alkyl oxadiazole beta3 adrenergic receptor agonistD D Feng, T Biftu, M R Candelore, et al.
Journal of Medicinal Chemistry|October 29, 2000
Discovery of a potent, orally bioavailable beta(3) adrenergic receptor agonist, (R)-N-[4-[2-[[2-hydroxy-2-(3-pyridinyl)ethyl]amino]ethyl]phenyl]-4-[4 -[4-(trifluoromethyl)phenyl]thiazol-2-yl]benzenesulfonamideR J Mathvink, J S Tolman, D Chitty, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2000
Synthesis and SAR of benzyl and phenoxymethylene oxadiazole benzenesulfonamides as selective beta3 adrenergic receptor agonist antiobesity agentsT Biftu, D D Feng, G B Liang, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Journal of Clinical Microbiology|May 23, 2008
Development of multiplex PCR-ligase detection reaction assay for detection of West Nile virusS Rondini, M R Pingle, S Das, et al.
Bioorganic & Medicinal Chemistry Letters|September 15, 2000
Potent, selective 3-pyridylethanolamine beta3 adrenergic receptor agonists possessing a thiazole benzenesulfonamide pharmacophoreR J Mathvink, J S Tolman, D Chitty, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2000
Human beta3-adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamidesL L Brockunier, E R Parmee, H O Ok, et al.
Bioorganic & Medicinal Chemistry Letters|July 29, 2000
Substituted oxazole benzenesulfonamides as potent human beta3 adrenergic receptor agonistsH O Ok, L B Reigle, M R Candelore, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2001
Beta(3)-adrenoceptor agonist-induced increases in lipolysis, metabolic rate, facial flushing, and reflex tachycardia in anesthetized rhesus monkeysG J Hom, M J Forrest, T J Bach, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
3-Pyridylethanolamines: potent and selective human beta 3 adrenergic receptor agonistsE M Naylor, V J Colandrea, M R Candelore, et al.
Bioorganic & Medicinal Chemistry Letters|May 26, 1999
L-770,644: a potent and selective human beta3 adrenergic receptor agonist with improved oral bioavailabilityT L Shih, M R Candelore, M A Cascieri, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2000
Discovery of an orally bioavailable alkyl oxadiazole beta3 adrenergic receptor agonistD D Feng, T Biftu, M R Candelore, et al.
Journal of Medicinal Chemistry|October 29, 2000
Discovery of a potent, orally bioavailable beta(3) adrenergic receptor agonist, (R)-N-[4-[2-[[2-hydroxy-2-(3-pyridinyl)ethyl]amino]ethyl]phenyl]-4-[4 -[4-(trifluoromethyl)phenyl]thiazol-2-yl]benzenesulfonamideR J Mathvink, J S Tolman, D Chitty, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2000
Synthesis and SAR of benzyl and phenoxymethylene oxadiazole benzenesulfonamides as selective beta3 adrenergic receptor agonist antiobesity agentsT Biftu, D D Feng, G B Liang, et al.
Pageof 7